Trained inspectors. Trusted outcomes.
FDA 483s often stem from poor inspection practices.Syrviatek’s test sets and qualification programs empower your team to detect defects with […]
FDA 483s often stem from poor inspection practices.Syrviatek’s test sets and qualification programs empower your team to detect defects with […]
Certified irregular particles offer a powerful edge in test set creation ensuring realistic defect simulation, inspector qualification consistency, and regulatory
Difficult-to-inspect pharmaceutical products—like lyophilized drugs, suspensions, and opaque solutions—pose major challenges for visual inspection due to their complex formats and
In today’s pharmaceutical and biotech industries, compliance isn’t optional—it’s essential. From injectable drug production to diagnostic testing, every detail matters.
At Syrviatek Laboratories, we pride ourselves on delivering low lead times without compromising quality. From our FDA-certified, ISO 9001-certified facility
In today’s regulatory environment, FDA warning letters often stem from gaps in visual inspection programs—from inadequate defect libraries to poorly
🔬 Visual Inspection of Lyophilized Products: Why It Matters Lyophilized drugs are vital for stability, but they’re also prone to
🔍 Visual Inspection in Injection Molded Parts: Why It Matters In the medical and pharmaceutical industries, precision isn’t optional—it’s critical.
🔍 Visual Inspection in Injection Molding: Why It Matters In injection molding, visual inspection is a critical step to ensure
🧪 Enhancing Visual Inspection Training with Irregular Particles: A Regulatory Perspective In pharmaceutical manufacturing, visual inspection is a critical step